HARVARD BIOSCIENCE INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Harvard Bioscience Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Harvard Bioscience Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$4.8M, a 288% decline year-over-year.
  • Harvard Bioscience Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$14.2M, a 336% decline year-over-year.
  • Harvard Bioscience Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$3.42M, a 64.1% increase from 2022.
  • Harvard Bioscience Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$9.52M, a 3204% decline from 2021.
  • Harvard Bioscience Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$288K, a 96.3% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$14.2M -$4.8M -$3.56M -288% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 -$10.7M -$2.93M -$1.95M -199% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$8.73M -$4.69M -$5.32M -855% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$3.42M -$1.82M -$152K -9.12% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$3.26M -$1.24M +$2.17M +63.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$5.43M -$980K -$3.42M -140% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$2.01M $622K +$7.5M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$9.52M -$1.67M -$2.63M -273% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$6.89M -$3.41M -$3.24M -1903% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$3.65M $2.44M +$2.85M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$6.5M -$6.88M -$6.21M -928% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q4 2021 -$288K $961K +$1.58M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$1.86M -$170K +$928K +84.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$2.79M -$410K +$1.17M +74.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$3.96M -$669K +$3.85M +85.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$7.81M -$615K -$1.17M -212% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$6.65M -$1.1M +$1.52M +58.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$8.17M -$1.58M -$1.33M -540% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$6.83M -$4.52M -$2.15M -90.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$4.69M $550K -$2.31M -80.8% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-16
Q3 2019 -$2.38M -$2.62M -$2.36M -923% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$11K -$247K +$1.22M +83.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$1.23M -$2.37M +$1.69M +41.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 -$2.92M $2.86M +$1.86M +186% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$4.79M -$256K +$161K +38.6% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-16
Q2 2018 -$4.95M -$1.46M -$1.08M -284% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-16
Q1 2018 -$3.86M -$4.06M -$3M -281% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-16
Q4 2017 -$865K $999K +$2.32M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$3.18M -$417K +$1.22M +74.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$4.41M -$381K +$332K +46.6% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$4.74M -$1.07M -$430K -67.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$4.31M -$1.32M +$15.8M +92.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 -$20.1M -$1.64M -$791K -93.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-16
Q2 2016 -$19.3M -$713K -$1.06M -304% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-16
Q1 2016 -$18.3M -$636K +$765K +54.6% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-16
Q4 2015 -$19M -$17.1M -$17.1M -90111% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-17
Q3 2015 -$1.92M -$847K -$1.48M -234% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-17
Q2 2015 -$438K $349K -$673K -65.9% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-17
Q1 2015 $235K -$1.4M -$2.12M -295% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-17
Q4 2014 $2.36M -$19K +$737K +97.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-04-29
Q3 2014 $1.62M $633K +$1.62M Jul 1, 2014 Sep 30, 2014 10-K 2016-04-29
Q2 2014 $1K $1.02M +$1.21M Apr 1, 2014 Jun 30, 2014 10-K 2016-04-29
Q1 2014 -$1.21M $719K +$623K +649% Jan 1, 2014 Mar 31, 2014 10-K 2016-04-29
Q4 2013 -$1.83M -$756K -$1.96M -163% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 $126K -$984K -$851K -640% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 $977K -$186K -$960K -124% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 $1.94M $96K -$433K -81.9% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 $2.37M $1.2M +$462K +62.6% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 $1.91M -$133K -$161K -575% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 $2.07M $774K -$596K -43.5% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 $2.67M $529K -$1.15M -68.4% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 $3.81M $738K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 $28K -$12.7M -99.8% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-18
Q2 2011 $1.37M -$512K -27.2% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-18
Q1 2011 $1.68M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-18
Q3 2010 $12.7M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 $1.88M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.